Form 13-F position report

HEALTHEQUITY INC

Reported by ASHFORD CAPITAL MANAGEMENT INC

HQY CUSIP 42226A107 Manager CIK 0000897070

Reported 358,048 shares, up 3,758 (1.1%) from the prior quarter.

Reported value -8.0%; share count 1.1% vs. the prior quarter.

Added
% of reported 13F value 3.12% This manager · Q2 2022
Shares 358,048 Quarter-end amount reported
Reported value $21,981,000 Fair value at quarter end
Consecutive quarters held 17 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 14293000
2022-03-31 23893000
2022-06-30 21981000
2022-09-30 22826000
2022-12-31 20285971
2023-03-31 23413900
2023-06-30 26505477
2023-09-30 29532581
2023-12-31 27095617
2024-03-31 27877625
2024-06-30 26522188
2024-09-30 24982421
2024-12-31 25840486
2025-03-31 24301662
2025-06-30 29270363
2025-09-30 25773934
2025-12-31 24892544
2026-03-31 22269817
2026-06-30 22890791
2026-09-30 22154453

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for HEALTHEQUITY INC held by ASHFORD CAPITAL MANAGEMENT INC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 250,446 -2,995 (-1.2%) 2.4% $22,154,453 2026-11-13
Q2 2026 Reduced 253,441 -13,040 (-4.9%) 2.45% $22,890,791 2026-08-21
Q1 2026 Reduced 266,481 -5,242 (-1.9%) 2.75% $22,269,817 2026-05-15
Q4 2025 Reduced 271,723 -240 (-0.1%) 2.77% $24,892,544 2026-02-17
Q3 2025 Reduced 271,963 -7,441 (-2.7%) 2.87% $25,773,934 2025-11-14
Q2 2025 Added 279,404 +4,405 (1.6%) 3.44% $29,270,363 2025-08-18
Q1 2025 Added 274,999 +5,687 (2.1%) 3.13% $24,301,662 2025-05-15
Q4 2024 Reduced 269,312 -35,910 (-11.8%) 3.05% $25,840,486 2025-02-18
Q3 2024 Reduced 305,222 -2,460 (-0.8%) 3.12% $24,982,421 2024-11-18
Q2 2024 Reduced 307,682 -33,830 (-9.9%) 3.58% $26,522,188 2024-08-15
Q1 2024 Reduced 341,512 -67,170 (-16.4%) 3.77% $27,877,625 2024-05-15
Q4 2023 Added 408,682 +4,403 (1.1%) 3.63% $27,095,617 2024-02-15
Q3 2023 Reduced 404,279 -15,510 (-3.7%) 4.35% $29,532,581 2023-11-15
Q2 2023 Added 419,789 +20,983 (5.3%) 3.7% $26,505,477 2023-08-14
Q1 2023 Added 398,806 +69,702 (21.2%) 3.51% $23,413,900 2023-05-15
Q4 2022 Reduced 329,104 -10,727 (-3.2%) 3.15% $20,285,971 2023-02-15
Q3 2022 Reduced 339,831 -18,217 (-5.1%) 3.48% $22,826,000 2022-11-16
Q2 2022 Added 358,048 +3,758 (1.1%) 3.12% $21,981,000 2022-08-15
Q1 2022 Added 354,290 +31,220 (9.7%) 2.57% $23,893,000 2022-05-16
Q4 2021 Reduced 323,070 -40,611 (-11.2%) 1.43% $14,293,000 2022-02-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

324 managers reported HEALTHEQUITY INC for Q2 2022.

Managers reporting HEALTHEQUITY INC in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 9,771,455 +348,447 0.02% $599,869,000 29 qtrs
VANGUARD GROUP INC Added 8,142,880 +144,552 0.01% $499,892,000 32 qtrs
WASATCH ADVISORS INC Reduced 6,628,751 -1,010,184 2.57% $406,939,000 32 qtrs
FMR LLC Added 3,589,800 +373,264 0.02% $220,377,822 29 qtrs
WILLIAM BLAIR INVESTMENT MANAGEMENT LLC Reduced 2,687,591 -424,803 0.61% $164,991,000 10 qtrs
STATE STREET CORPORATION Reduced 2,597,911 -44,747 < 0.01% $159,486,000 32 qtrs
JPMorgan Chase & Co Reduced 2,457,011 -212,694 0.02% $150,837,000 32 qtrs
MACKENZIE FINANCIAL CORP Reduced 2,053,812 -7,161 0.2% $126,084,000 7 qtrs
ArrowMark Colorado Holdings LLC Reduced 1,847,890 -85,846 1.3% $113,442,000 10 qtrs
BROWN ADVISORY INC Added 1,826,705 +15,650 0.21% $112,141,000 18 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 15, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
358,048
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.